Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2024 –2031 | |
|
|
USD 8.68 Billion |
| USD 55.24 Billion | |
| % | |
|
The Global Postpartum Depression Market size in 2023 is USD 8.68 billion. The market share is projected to grow at a CAGR of 30.25% and reach USD 55.24 billion by 2031.
Postpartum depression (PPD) is a complex mix of physical, emotional, and behavioral changes that occur in women after giving birth. It's a significant subset of mood disorders, with symptoms ranging from sadness and anxiety to severe depression. The Global Postpartum Depression Market encompasses a variety of products, including antidepressants, therapies, and natural supplements, all aimed at addressing this critical mental health issue. According to The American Journal of Obstetrics and Gynecology, the prevalence of postpartum depression (PPD) nearly doubled from 9.4% in 2010 to 19.3% in 2021, reflecting growing recognition and diagnosis of the condition. The surge in prevalence has significantly contributed to the expansion of the global PPD market, as the increased need for effective treatments drives demand for innovative therapies like brexanolone (Zulresso) and other mental health interventions, leading to steady market growth.
Data Bridge Market Research Market Report provides details of new recent developments, market share, market trends on the basis of its segmentations and regional analysis, the impact of market players, analyses of opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market, contact Data Bridge Market Research’s team of expert analysts. Our team will help you make informed market decisions to achieve business growth.
|
Global Postpartum Depression Report Metric Details
|
|
||
|
Report Metric
|
Details
|
||
|
Forecast Period
|
2024-2031
|
||
|
Base Year
|
2023
|
||
|
Historic Year
|
2022 (Customizable 2016-2021)
|
||
|
Measuring Unit
|
USD Billion
|
||
|
Data Pointers
|
Market value, growth rate, market segments, geographical coverage, market players, and market scenario, in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
||
The decreasing stigma around mental health is playing a crucial role in the growth of the global postpartum depression (PPD) market, as more women feel empowered to seek help for PPD without fear of judgment. Shifting societal attitudes has increased demand for effective treatments and therapies, driving the market's expansion and encouraging continued innovation in addressing this critical aspect of maternal health. As a result, Databridge Market Research dived into comprehensively analyzing the market and unveiled that the Global Postpartum Depression Market is increasing at a CAGR of 30.25%. Our detailed analysis forecasts that the market is valued at USD 8.68 billion in 2023 and is expected to grow up to USD 55.24 billion by 2031. Our meticulously created report, developed through comprehensive research and analytics, is a distinguished paper that unveils eye-opening data about the market.
Global Postpartum Depression Market Dynamics
Rising investment in healthcare infrastructure
According to the World Health Organization (WHO)'s Global Health Expenditure Report 2023, global spending on health reached a record high of USD 9.8 trillion, or 10.3% of global GDP. Substantial investment enhances the availability of resources for research, treatment, and improved access to mental health services, thereby supporting the development and dissemination of effective postpartum depression therapies. Consequently, financial boost fosters the Global Postpartum Depression Market's expansion by addressing the rising demand for postpartum depression interventions.
Reduced stigma surrounding mental health
Reduced stigma surrounding mental health issues has significantly encouraged more women to seek help for postpartum depression (PPD). According to American Psychological Association, adults aged 35 to 44 saw the most significant rise in mental health diagnoses, with 45% reporting mental illness in 2023, up from 31% in 2019. Shift towards mental health awareness supports the growth of the global postpartum depression market by increasing the demand for effective treatments, interventions ad diagnoses.
Rising number of research and development activities
The development of new therapies, such as brexanolone (Zulresso), ketamine-based therapies, and advancements in antidepressants provide new options that target different neurotransmitter systems, offering hope to the patients who may not respond to conventional medications. Digital health mobile applications for cognitive behavioral therapy (CBT) and telehealth platforms enhance the accessibility and personalization of care, allowing for real-time, remote support, and tailored treatment plans. These innovations collectively represent significant opportunities for growth in the global postpartum depression market, as they address diverse patient needs, improve treatment outcomes, and expand the reach of effective care.
High costs associated with Postpartum Depression restricting the market growth
High costs associated with postpartum depression (PPD) treatment restrict market growth by limiting access for many patients. The significant expense of this novel therapy can lead to insurance coverage challenges and out-of-pocket costs that are prohibitive for some women. Furthermore, the cost of comprehensive mental health programs and advanced treatments can strain healthcare budgets, particularly in lower-income regions. These financial barriers restrict widespread adoption and limit the growth potential of the Global Postpartum Depression Market by preventing broader access to effective care.
Lack of standardized screening
The lack of standardized screening for postpartum depression (PPD) significantly restrains the growth of the global market by leading to missed diagnoses and lower treatment rates. In regions such as Southeast Asia and Africa, where screening practices are less consistent, a substantial number of women are not identified and treated for PPD, resulting in delayed intervention and reduced treatment uptake. This inconsistency in screening impedes market growth by limiting the number of patients accessing effective treatments and creating disparities in care, ultimately constraining the expansion of the global postpartum depression market.
Regulatory hurdles
In the Global postpartum depression (PPD) market, approval delays are a major regulatory constraint that are frequently caused by the drawn-out and intricate procedures mandated by organizations such as the FDA and EMA. For instance, it took several years for the first drug licensed particularly for PPD, brexanolone (Zulresso), to get the approval. The entire process from first proposal to approval took almost ten years, despite the breakthrough status, showing how regulatory obstacles can cause delays in the availability of novel medications. Such Delays hamper the introduction of novel medicines, which can hinder the Global Postpartum Depression Market expansion.
Global Postpartum Depression Market Scope and Trends
|
Global Postpartum Depression Market Segmentations Overview
|
|
|
Market
|
Sub-Segments
|
|
Type
|
Postpartum Blues, Postpartum Anxiety, Postpartum Obsessive Compulsive Disorder, Postpartum Panic Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Psychosis, Others
|
|
Treatment
|
Psychotherapy, Medication, Supplements, Others
|
|
Route of Administration
|
Oral, Parenteral, Others
|
|
End-Users
|
Hospitals, Specialty Clinics, Homecare, Others
|
|
Distribution Channel
|
Broadcast Monitoring, Social Media Monitoring, Online Monitoring, Print Monitoring
|
|
Distribution Channel
|
Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others
|
Global Postpartum Depression Market Regional Analysis- Market Trends
|
Global Postpartum Depression Market Regional Overview
|
|
|
|
Region
|
Countries
|
|
|
Europe
|
Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe
|
|
|
APAC
|
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific
|
|
|
North America
|
U.S., Canada, and Mexico
|
|
|
MEA
|
Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East, and Africa
|
|
|
South America
|
Brazil, Argentina, and Rest of South America
|
|
Key Insights
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.